Results
|
|
4161.
|
Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu. [electronic resource] by
- Schwaab, T
- Lewis, L D
- Cole, B F
- Deo, Y
- Fanger, M W
- Wallace, P
- Guyre, P M
- Kaufman, P A
- Heaney, J A
- Schned, A R
- Harris, R D
- Ernstoff, M S
Producer: 20010322
In:
Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 24
Availability: No items available.
|
|
|
4162.
|
|
|
|
4163.
|
|
|
|
4164.
|
|
|
|
4165.
|
|
|
|
4166.
|
|
|
|
4167.
|
|
|
|
4168.
|
|
|
|
4169.
|
|
|
|
4170.
|
|
|
|
4171.
|
|
|
|
4172.
|
|
|
|
4173.
|
|
|
|
4174.
|
|
|
|
4175.
|
|
|
|
4176.
|
|
|
|
4177.
|
|
|
|
4178.
|
|
|
|
4179.
|
|
|
|
4180.
|
|